G

Granules

Vertically integrated API and dosage manufacturer

Temporary Quality Assurance Assistant

ContractPosted on 10/21/2026
$20 - $24/hr
Entry
Chantilly, VA, USA
In Person
Manufacturing Quality & TestValidation, Compliance & Quality Systems

About the job

Requirements
  • A high school diploma or equivalent is required.
  • Strong attention to detail and organizational skills are required.
  • Basic computer proficiency, including scanning, electronic filing, and navigating shared folders, is required.
  • Ability to follow established procedures and work instructions in a regulated environment is required.
  • Strong time management skills and the ability to work independently, adapt to changing priorities, and manage multiple tasks effectively are required.
  • A reliable, proactive, and dependable work ethic is required.
  • Effective communication and teamwork skills are required.
  • Ability to sit, stand, and walk for extended periods is required.
  • Ability to lift and carry files or boxes weighing up to 25 pounds is required.
Responsibilities
  • Assist with Quality Assurance product release documentation activities under departmental guidance.
  • Perform routine checks to support compliance, organization, and warehouse housekeeping standards.
  • Support Quality Assurance and perform other duties as assigned.
  • Review, organize, and verify training records, batch records, certificates of analysis, and logbooks.
  • Scan, upload, and electronically file quality and production documents.
  • Maintain and organize Quality Assurance document storage areas and document archives.
  • Collaborate with Quality Assurance personnel to ensure accurate documentation and record management.
Desired Qualifications
  • Experience working with documents, records management, inventory, warehouse operations, or administrative support is preferred.
  • Experience in a manufacturing, quality, or regulated environment is helpful but not required.

About the company

Granules India makes APIs, PFIs, and finished dosages, using large-scale, vertically integrated plants that control production from base chemicals to final medicines. Its products include common off-patent APIs like Paracetamol, Ibuprofen, Metformin, and Guaifenesin, and it is expanding into more complex areas such as MUPS, oncology, and peptide therapies with US FDA approvals. The company differentiates itself through full vertical integration, large scale, and a global manufacturing footprint that supports both contract manufacturing and its own branded products, offering supply security and cost competitiveness. Its goal is to deliver reliable, affordable medicines to customers worldwide while growing capabilities in complex therapies and pursuing sustainable practices like green chemistry.

Company Size

501-1,000

Company Stage

N/A

Total Funding

N/A

Headquarters

N/A

Founded

2014

Get referred to Granules

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q3 FY26 revenue rose 22% to INR 1,388 crores, led by North America and Europe.
  • July 2026 inspections at Genome Valley and Chantilly improved regulatory optionality and capacity.
  • Europe grew 151% year-on-year in FY26, while peptide CDMO opened a new revenue vertical.

What critics are saying

  • FDA warning letter dated February 26, 2025 threatens Gagillapur product approvals until remediation closes.
  • Reuters on April 9, 2026 reported record-keeping and contamination concerns still burden management.
  • Any second FDA action at Gagillapur can shut U.S. launches and damage Granules' generics franchise.

What makes Granules unique

  • Granules integrates APIs, PFIs, and dosages, preserving cost control across the value chain.
  • February 2025 Senn Chemicals acquisition adds peptide CDMO capabilities and European regulated-market access.
  • Granules shipped in 80 countries and won 94 approvals by August 2026.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Flexible Work Hours